Pest Management Regulatory Agency
23 April 2012
ISSN: 1925-1025 (PDF version)
Catalogue number: H113-28/2012-4E-PDF (PDF version)
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
After a re-evaluation of the antimicrobial active ingredient poly[oxyethylene(dimethyliminio) ethylene(dimethyliminio)ethylene dichloride], hereafter referred to as POD, Health Canada's Pest Management Regulatory Agency (PMRA), under the authority of the
Pest Control Products Act and
Regulations, is granting continued registration of products containing POD for sale and use in Canada.
An evaluation of available scientific information found that products containing POD do not present unacceptable risks to human health or the environment when used according to label directions. As a condition of the continued registration of POD uses, new risk-reduction measures must be included on the labels of all products. Additional confirmatory data are being requested as a result of this re-evaluation
The regulatory approach for the re-evaluation of POD was first presented in Proposed Re evaluation Decision PRVD2011-13, Poly[oxyethylene(dimethyliminio) ethylene(dimethyliminio)ethylene dichloride] (POD), a consultation documentFootnote 1. This Re evaluation DecisionFootnote 2 describes this stage of the PMRA's regulatory process for the re evaluation of POD as well as summarizes the Agency's decision and the reasons for it. No comments were received during the consultation process. This decision is consistent with the proposed re-evaluation decision stated in PRVD2011-13. To comply with this decision, registrants of products containing POD will be informed of the specific requirements affecting their product registration(s) and of regulatory options available to them.
The PMRA's pesticide re-evaluation program considers potential risks, as well as value, of pesticide products to ensure they meet modern standards established to protect human health and the environment. Regulatory Directive DIR2001-03, PMRA Re-evaluation Program, presents the details of the re-evaluation activities and program structure.
POD has been re-evaluated under Re-evaluation Program 1. This program relies as much as possible on foreign reviews, typically
United States Environmental Protection Agency
Reregistration Eligibility Decision documents. For products to be re-evaluated under Program 1, the foreign review must meet the following conditions:
Based on the outcome of foreign reviews and a review of the chemistry of Canadian products, the PMRA has made a regulatory decision and requires appropriate risk-reduction measures for Canadian uses of POD. In this decision, the PMRA took into account the Canadian use pattern and issues (for example, the federal
Toxic Substances Management Policy).
The United States Environmental Protection Agency re-evaluated POD and published its conclusions in a 2007 Reregistration Eligibility Decision.
For more details on the information presented in this Re-evaluation Decision, please refer to the Science Evaluation in the related Proposed Re-evaluation Decision PRVD2011-13, Poly[oxyethylene(dimethyliminio) ethylene(dimethyliminio)ethylene dichloride] (POD).
POD is an antimicrobial active ingredient used for control of algae in swimming pools, spas, hot tubs and decorative fountains. It is also registered for control of algae, bacteria and fungi in cooling towers, industrial air washing systems, metal working fluids, and starch solutions used in the production of paper, paperboard, and adhesives. Commercial products containing POD are applied by workers by open pour or liquid pump. Domestic products containing POD can be applied by homeowners by open pour.
POD is unlikely to affect your health when used according to the revised label directions.
People could be exposed to POD through residential and occupational exposure. The PMRA considers two key factors when assessing health risks: the levels at which no health effects occur and the levels to which people may be exposed. The dose levels used to assess risks are established to protect the most sensitive human population (for example, children and nursing mothers). Only uses for which exposure is well below levels that cause no effects in animal testing are considered acceptable for continued registration.
POD is unlikely to affect human health provided that the required risk-reduction measures to further protect workers are implemented.
Non-target organisms could be exposed to POD in the environment as a result of effluent discharge to waters adjacent to manufacturing facilities. Environmental risk is assessed by the risk quotient method--the ratio of the estimated environmental concentration to the relevant effects endpoint of concern. The resulting risk quotients are compared to corresponding levels of concern. A risk quotient less than the level of concern is considered a low risk to non-target organisms, whereas a risk quotient greater than the level of concern indicates some degree of risk.
POD is unlikely to pose an adverse effect to the environment if used according to revised labels. Improvements to environmental label statements and risk-reduction measures are required.
Labels of registered pesticide products include specific instructions for use. Directions include risk-reduction measures to protect human and environmental health. These directions must be followed by law. As a result of the re-evaluation of POD, the PMRA is requiring further risk-reduction measures for product labels.
Appendix I lists all required label amendments, including additional instructions related to basic hygiene practices.
Data are required as a condition of continued registration under section 12 of the Pest Control Products Act. The registrants of this active ingredient must provide these data or an acceptable scientific rationale to the PMRA within the timeline specified in the decision letter. Appendix II lists all data requirements.
Any person may file a notice of objectionFootnote 3 regarding this decision on POD within 60 days from the date of publication of this Re-evaluation Decision. For more information regarding the basis for objecting (which must be based on scientific grounds), please refer to the Pesticides and Pest Management portion of Health Canada's website (Request a Reconsideration of Decision) or contact the PMRA's Pest Management Information Service.
The label amendments presented below do not include all label requirements for individual end-use products, such as first aid statements, disposal statements, precautionary statements and supplementary protective equipment. Additional information on labels of currently registered products should not be removed unless it contradicts the above label statements.
The labels of end-use products in Canada must be amended to include the following statements to further protect workers and the environment.
KEEP OUT OF REACH OF CHILDREN. Do not mix with any other chemical. Harmful if swallowed. Avoid contact with skin and eyes. Wear a long-sleeved shirt and long pants, chemical-resistant gloves during handling, clean-up and repair activities. In addition, a chemical-resistant apron is required for workers handling end-use products in industrial settings. Wash thoroughly after handling. Immediately remove contaminated clothing and wash before reuse.
KEEP OUT OF REACH OF CHILDREN. Do not mix with any other chemical. Harmful if swallowed. Avoid contact with skin and eyes.
DO NOT discharge effluent containing this product into sewer systems, lakes, streams, ponds, estuaries, oceans, and other waters.
DO NOT contaminate irrigation or drinking water supplies or aquatic habitats by cleaning of equipment or disposal of wastes.
DO NOT use in decorative fountains with fish.
Toxic to aquatic organisms.
The following data are required as a condition of continued registration under section 12 of the Pest Control Products Act. The registrants of this active ingredient are required to provide these data or an acceptable scientific rationale within the timeline specified in the decision letter that will be sent to registrant(s) of the technical active ingredients by the PMRA.
"Consultation statement" as required by subsection 28(2) of the Pest Control Products Act.
"Decision statement" as required by subsection 28(5) of the Pest Control Products Act.
As per subsection 35(1) of the Pest Control Products Act.